Mahindra & Mahindra Financial Services | Axis Bank | ICICI Bank | Wipro | Bharti Airtel | Tata Motors | TCS | Educomp Solutions | Bosch | Orchid Chemicals | Pipavav Defence | Gitanjali Gems | Bhushan Steel | Gujarat Fluorochemicals | Shree Renuka | Jain Irrigation | NALCO | JK Tyre and Gujarat Apollo are stocks, which are in the news today.
Tata Steel | GMR Infrastructure | Rain Commodities | IVRCL | Voltas | Educomp | Escorts | Orbit Corp | Neyveli Lignite | Deccan Chronicle Holdings | JHS Svendgaard | Ess Dee Aluminium | Punj Lloyd | Strides Arcolab | JBF Industries | Pidilite Industries | Everonn Education | SAIL and Jain Irrigation are stocks, which are in the news today.
Around Rs 47,359 crore of loans were referred to the corporate debt restructuring (CDR) in just one month, which is over half of what was referred in the last year
K Raghavendra Rao, chairman and managing director, Orchid Chemicals says the company has approached State Bank of India to delay the repayment of its USD 300 million debt.
Ashu Madan, President, Core Client Group of Religare Securities recommended to avoid Orchid Chemicals.
Sudarshan Sukhani of s2analytics.com says momentum traders should consider buying Titan Industries only for the short-term.
Rajesh Agarwal of Eastern Financiers recommends buying Mahindra Ugine, Polaris Financial Technology, SREI Infrastructure and Orchid Chemicals.
Rajesh Agarwal of Eastern Financiers recommended to buy Mahindra Ugine for a target price of Rs 77 and buy Polaris for a target price of Rs 127.
According to SP Tulsian of sptulsian.com, one should expect a level of Rs 60 on Orchid Chemicals after the clean chit from USFDA for Chennai facility.
Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
Sharmila Joshi, head of equity at Peerless Securities says one should avoid Orchid Chemicals. One can buy Ipca Labs on correction, he adds.
Parag Doctor, head - trading strategies at Keynote Capital's advised exiting Orchid Chemicals. He also said one could shift to largecap names like Lupin and Dr Reddys Labs.
Pharma stocks like Dr Reddys, Lupin, Divis Labs, Glenmark and Orchid Chemicals will getting astrological support, says Satish Gupta of Astrostocktips.
In CNBC-TV18's popular show Bull's Eye, Aashish Tater, Fortunewizard.com shares trading strategy of the day.
Parag Doctor, Head of Trading Strategies at Keynote Capital advised exiting Orchid Chemicals at around Rs 80-85 levels.
K Raghavendra Rao, chief managing director, Orchid Chemicals and Pharmaceuticals says the company will continue to supply Cephalosporin to regulated markets including US.
Sharmila Joshi, Head of Equity, Peerless Securities Ltd. is of the view that one can sell Orchid Chemicals,
Sudarshan Sukhani, s2analytics.com advises to exit from Orchid Chemicals and one can buy SBI.
One can stay away from Orchid Chemicals, says Sudarshan Sukhani of s2analytics.com.
Technical analyst, Sudarshan Sukhani, s2analytics.com shared his reading and outlook on market and specific stocks.
Technical analyst, Sudarshan Sukhani, s2analytics.com said that we are entering a very strong resistance zone but that does not mean the index will stop here. The chances are that it will become very choppy and essentially untradeable.
In CNBC-TV18's popular show Bull's Eye, Rajesh Agarwal, Eastern Financiers shares trading strategy of the day.
SP Tulsian, sptulsian.com advises traders to buy Orchid Chemicals on dips from long term perspective.
Sudarshan Sukhani, s2analytics.com is of the view that one should avoid Orchid Chemicals and Jindal Poly.
In CNBC-TV18's popular show Bull's Eye, Rajesh Agarwal, Eastern Financiers shares trading strategy of the day.